Crossmark

ROS-1 TKI for the treatment of concurrent sarcomatoid transformation and acquired ROS-1 F2004C mutation in a lung adenocarcinoma patient

Published Print: 2022-01

Authors

Ko, H.-J.

Hsu, C.-K.

Yeh, Y.-C.

Huang, H.-C. http://orcid.org/0000-0002-7384-6838
License Information

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2021-09-14
More Information

This article is maintained by: Elsevier

Article Title: ROS-1 TKI for the treatment of concurrent sarcomatoid transformation and acquired ROS-1 F2004C mutation in a lung adenocarcinoma patient

Journal Title: Pulmonology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pulmoe.2021.08.009

Content Type: simple-article

Copyright: © 2021 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U.

Document is current